Form 4: Nanophase Technologies Corp: Chief Operating Officer Kevin Cureton Increases Stake in Company
SEC Form 4
Kevin Cureton, Chief Operating Officer of Nanophase Technologies Corp, reports purchasing additional shares of common stock, increasing his direct ownership.
Summary
- On June 21, 2024, Kevin Cureton, the Chief Operating Officer of Nanophase Technologies Corp, purchased multiple blocks of common stock at prices ranging from $1.45 to $1.49 per share, totaling 7,000 shares.
- On June 24, 2024, Mr. Cureton purchased an additional 4,575 shares at $1.498 per share.
- Following these transactions, Mr. Cureton directly owns 187,496 shares of Nanophase Technologies Corp common stock.
- Mr. Cureton also holds derivative securities in the form of rights to purchase common stock at various exercise prices and expiration dates.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the COO increasing his stake in the company, which can be interpreted as a sign of confidence. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- The COO's increased investment in the company may signal confidence in Nanophase Technologies' future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company insider believes the company's stock is undervalued or that the company's future prospects are strong. However, it is only one data point and should be considered alongside other factors when evaluating a company.
Stakeholder Impact
- The increased stake of the COO could improve investor confidence.
Key Dates
| Date | Description |
|---|---|
| 02/18/2016 | Date of grant for options to purchase 50,000 shares of common stock at $0.44, expiring 02/18/2025 |
| 02/23/2017 | Date of grant for options to purchase 43,500 shares of common stock at $0.42, expiring 02/23/2026 |
| 02/21/2018 | Date of grant for options to purchase 50,000 shares of common stock at $0.68, expiring 02/21/2027 |
| 05/23/2019 | Date of grant for options to purchase 80,000 shares of common stock at $0.82, expiring 05/23/2028 |
| 05/22/2020 | Date of grant for options to purchase 16,500 shares of common stock at $0.51, expiring 05/22/2029 |
| 06/18/2021 | Date of grant for options to purchase 90,000 shares of common stock at $0.45, expiring 06/18/2027 |
| 12/28/2022 | Date of grant for options to purchase 90,000 shares of common stock at $4.17, expiring 12/28/2028 |
| 12/20/2023 | Date of grant for options to purchase 72,000 shares of common stock at $1.165, expiring 12/20/2029 |
| 06/21/2024 | Kevin Cureton purchased 7,000 shares of common stock at prices ranging from $1.45 to $1.49 per share. |
| 06/24/2024 | Kevin Cureton purchased 4,575 shares of common stock at $1.498 per share. |
| 06/25/2024 | Date of signature for the Form 4 filing. |
| 12/27/2024 | Date of grant for options to purchase 12,600 shares of common stock at $0.61, expiring 12/27/2030 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.